Ergoteles’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Ergoteles’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,000	Closed	-$499K	–	979
2023 Q2	$499K	Sell	13,000 -4,062	-24%	-$104K	0.02%	643
2023 Q1	$395K	Sell	17,062 -309	-2%	-$7.37K	0.02%	818
2022 Q4	$455K	Buy	+17,371	New	+$385K	0.02%	739

Ergoteles's KDNY Position: Q3 2023 in Review

Ergoteles sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 13,000 shares — an estimated $499K sold.

Ergoteles first reported a position in KDNY in Q4 2022 and held it in 3 quarters. The position peaked at $499K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Ergoteles reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 13,000 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $499K.
Ergoteles first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Ergoteles's Chinook Therapeutics, Inc. Common Stock position peaked at $499K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.